Satellite Symposium:
Evolution of Antibiotic Therapy for the Treatment of Gram-Negative Pathogens (Not Official IDWeek Programming - This activity is supported by an unrestricted educational grant from Achaogen. - See Affiliated Events Guide)
Friday, October 28, 2016: 8:00 PM-10:00 PM
Room: 293-296

Learning Objectives:

All Satellite Symposia, Presentation Theaters, and Learning Lounges preceding and following the official program IDWeek 2016 are independently organized and executed.  IDWeek does not endorse or support the programming of any Symposia, Presentation Theater, or Learning Lounge.


Faculty:

 

Yehuda Carmeli, MD, MPH 

Professor in Medicine, Tel Aviv University

Head, National Institute for Antibiotic Resistance and Infection Control

Tel Aviv Medical Center.  Israel

 

Keith Rodvold, PharmD, F P, FIDSA

Professor of Pharmacy Practice and Pharmacy in Medicine

Colleges of Pharmacy and Medicine

Co-Director, Section of Infectious Diseases Pharmacotherapy

Department of Pharmacy Practice

University of Illinois at Chicago

 

Andrew F. Shorr, MD, MPH

Associate Chief, Pulmonary and Critical Care

Washington Hospital Center

Associate Professor of Medicine

Georgetown University Hospital

Washington, DC

Activity Objectives:

  • Describe the scope, prevalence and clinical implications of resistant Gram-negative pathogens.

  • Identify and understand the clinical impact of resistant Gram-negative bacteria and their various mechanisms of resistance on different types of infections and patient types in order to optimize treatment strategies.

  • List currently available and near-term pipeline treatment options for Gram-negative infections and how each of their profiles may help direct the selection of optimal antibiotic therapy in clinical practice.

  • Review the evolution of the newer antibiotics with a focus on aminoglycosides and how to optimize treatment strategies that include this class.

 

Credit Designation:

Center for Education Development designates this live educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™, 2.0 ANCC credits, or 2.0 CPE credits (NEED THE NUMBER).

Agenda subject to change and was provided by:

The Center for Education Development; 601 Route 206, 26-409; Hillsborough, NJ; 908-617-0177;Activitymanager@CEDevelopment.org.

Target Audience: Infectious diseases physicians

Presentations:
8:00 PM
Registration & Buffet
8:05 PM
The Clinical Implications of Resistant Gram-Negative Pathogens
8:35 PM
Gram-Negative Resistance and Its Impact on Treatment Decisions
9:05 PM
The Evolution of Antibiotics to Treat Gram-Negative Pathogens
9:35 PM
Question & Answers

CME Credits: No CME credit is offered for this session.

ACPE Credits:

ACPE Number:


See more of: Satellite Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.